Gilead to Start Its Own Studies of Potential Coronavirus Treatment

A man wears a face mask while waiting for a public bus in the Chinatown section of San Francisco, California, on Feb. 25, 2020. Shannon Stapleton/Reuters

Gilead Sciences Inc. announced this week that it will start two studies to evaluate a drug as a potential treatment for the new coronavirus.

The drug remdesivir has been selected by international and U.S. health officials as a possible treatment for the virus, which has sickened over 80,000 people around the world, killing thousands.